Figure 1From: A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma Survival curve of 95 HCCA patients after surgical treatment. The median survival time for all the 95 HCCA patients was 21.5 months. The 1-, 3-, and 5-year survival rates were 72%, 26%, and 21%, respectively.Back to article page